Meraki Therapies Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2107 N 2090 St, Saint Elmo, IL 62458 Phone: 618-267-3959 |
Mrs. Victoria Lynn Pattillo, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 251d, Saint Elmo, IL 62458 Phone: 618-829-9121 Fax: 618-829-9121 |
News Archive
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
In a move to accelerate applications of a novel cancer detection and treatment technology, Manhattan Scientifics today announced that it has acquired all of Senior Scientific, LLC and its affiliate Scientific Nanomedicine Inc.
Researchers at the University of California, San Diego School of Medicine have identified the gene mutation responsible for a particularly severe form of pontocerebellar hypoplasia, a currently incurable neurodegenerative disease affecting children.
IBM today announced researchers from science and technology university ETH Zurich and CloudBroker, a high-performance cloud computing company, have partnered with IBM to use cloud computing technology to conduct cutting-edge research focused on developing new antibiotics to fight disease.
Smoking is the leading cause of lung cancer, and it is estimated that more than 159,000 people in the United States died from the disease last year. Most of these deaths were because the cancer had spread to other organ sites. Following their recent discovery of a protein pathway, Moffitt Cancer Center researchers are one step closer to understanding how lung cancer cells metastasize.
› Verified 1 days ago